[Idiopathic respiratory distress syndrome in premature infants].
D000138:Acidosis / Q000188:drug therapy; D001238:Asphyxia Neonatorum / Q000150:complications*; D001639:Bicarbonates / Q000627:therapeutic use; D005260:Female; D005333:Fetus / Q000502:physiology; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D006819:Hyaline Membrane Disease / Q000175:diagnosis; D007231:Infant, Newborn; D008074:Lipoproteins / Q000096:biosynthesis*; D008168:Lung / Q000502:physiology*; D010102:Oxygen Inhalation Therapy; D011247:Pregnancy; D011650:Pulmonary Alveoli / Q000503:physiopathology; D012121:Respiration, Artificial; D012127:Respiratory Distress Syndrome, Newborn / Q000209:etiology* / Q000401:mortality / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D012143:Respiratory Physiological Phenomena; D013499:Surface Properties; D013500:Surface Tension; D013501:Surface-Active Agents / Q000096:biosynthesis*; D014325:Tromethamine / Q000627:therapeutic use
D001639:Bicarbonates; D008074:Lipoproteins; D013501:Surface-Active Agents; D014325:Tromethamine; D005947:Glucose
Das idiopathische Atemnotsyndrom des Frühgeborenen.